FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment ...Middle East

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population. Read More

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment )

Also on site :

• Blake Lively Wins Legal Battle Against Justin Baldoni
• Tony Awards draw best audience in 6 years for CBS
• Ax-wielding man at Pacific Beach library faces preliminary hearing